celecoxib has been researched along with upamostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cyran, CC; Eschbach, R; Havla, L; Hirner, H; Ingrisch, M; Mack, B; Moser, M; Nikolaou, K; Paprottka, PM; Reiser, MF; Roßpunt, S; Sterzik, A; Zengel, P | 1 |
| Clevert, DA; Cyran, CC; Gires, O; Ingrisch, M; Mack, B; Nikolaou, K; Paprottka, PM; Reiser, MF; Roßpunt, S; Zengel, P | 1 |
2 other study(ies) available for celecoxib and upamostat
| Article | Year |
|---|---|
DCE-MRI biomarkers for monitoring an anti-angiogenic triple combination therapy in experimental hypopharynx carcinoma xenografts with immunohistochemical validation.
Topics: Angiogenesis Inhibitors; Animals; Biomarkers, Tumor; Carcinoma, Squamous Cell; Celecoxib; Combined Modality Therapy; Contrast Media; Dipeptides; Disease Models, Animal; Hypopharyngeal Neoplasms; Image Enhancement; Immunohistochemistry; Magnetic Resonance Imaging; Oximes; Piperazines; Pyrazoles; Rats; Rats, Nude; Reproducibility of Results; Sulfonamides; Xenograft Model Antitumor Assays | 2015 |
Reducing tumor growth and angiogenesis using a triple therapy measured with Contrast-enhanced ultrasound (CEUS).
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cell Line, Tumor; Cell Proliferation; Female; Humans; Hydroxamic Acids; Hypopharyngeal Neoplasms; Indoles; Neovascularization, Pathologic; Oximes; Piperazines; Rats; Sulfonamides; Treatment Outcome; Ultrasonography; Xenograft Model Antitumor Assays | 2015 |